%PDF-1.4
%
1 0 obj
<>>>
endobj
2 0 obj
<>stream
2017-07-20T12:27:45+02:00
2017-07-20T12:27:55+02:00
2017-07-20T12:27:55+02:00
Adobe InDesign CS6 (Macintosh)
uuid:18384729-42d5-864f-836b-21fe5f91eb29
xmp.did:FECAC8210C206811871FCBCEF710174A
xmp.id:95A56F480F2068118083D69AC0B19DC9
proof:pdf
xmp.iid:7EEA7F4919206811822ADAE46C0B0051
xmp.did:0080117407206811822AFEC59C9C9B56
xmp.did:FECAC8210C206811871FCBCEF710174A
default
converted
from application/x-indesign to application/pdf
Adobe InDesign CS6 (Macintosh)
/
2017-07-20T12:27:45+02:00
application/pdf
Adobe PDF Library 10.0.1
False
endstream
endobj
5 0 obj
<>
endobj
3 0 obj
<>
endobj
8 0 obj
<>
endobj
9 0 obj
<>
endobj
15 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[24.0709 24.0709 619.346 865.961]/Type/Page>>
endobj
16 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[24.0709 24.0709 619.346 865.961]/Type/Page>>
endobj
17 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[24.0709 24.0709 619.346 865.961]/Type/Page>>
endobj
18 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[24.0709 24.0709 619.346 865.961]/Type/Page>>
endobj
19 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[24.0709 24.0709 619.346 865.961]/Type/Page>>
endobj
20 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[24.0709 24.0709 619.346 865.961]/Type/Page>>
endobj
21 0 obj
<>/ExtGState<>>>/TrimBox[24.0709 24.0709 619.346 865.961]/Type/Page>>
endobj
42 0 obj
<>stream
q
0 0 643.417 890.031 re
W n
/CS0 CS 0 SCN
1.25 w
/GS0 gs
q 1 0 0 1 15 865.9606 cm
0 0 m
-15 0 l
613.417 0 m
628.417 0 l
0 -841.89 m
-15 -841.89 l
613.417 -841.89 m
628.417 -841.89 l
9.071 9.071 m
9.071 24.071 l
9.071 -850.961 m
9.071 -865.961 l
604.346 9.071 m
604.346 24.071 l
604.346 -850.961 m
604.346 -865.961 l
S
Q
1 SCN
0.25 w
q 1 0 0 1 15 865.9606 cm
0 0 m
-15 0 l
613.417 0 m
628.417 0 l
0 -841.89 m
-15 -841.89 l
613.417 -841.89 m
628.417 -841.89 l
9.071 9.071 m
9.071 24.071 l
9.071 -850.961 m
9.071 -865.961 l
604.346 9.071 m
604.346 24.071 l
604.346 -850.961 m
604.346 -865.961 l
S
Q
Q
endstream
endobj
25 0 obj
<>
endobj
24 0 obj
[/Separation/All/DeviceGray<>]
endobj
41 0 obj
<>stream
BT
/CS0 cs 1 scn
/GS0 gs
/C0_0 1 Tf
11 0 0 11 326.349 44.3345 Tm
<00120011>Tj
ET
q
0 g
/Fm0 Do
Q
/CS0 CS 1 SCN
0.8 w
q 1 0 0 1 95.6456 754.7828 cm
0 0 m
95.87 0 l
S
Q
BT
/T1_0 1 Tf
16 0 0 16 95.6456 756.3827 Tm
(Referencias)Tj
0 0 0 0.8 k
/C0_1 1 Tf
9 0 0 9 110.3858 727.4882 Tm
<00720001>Tj
/T1_1 1 Tf
-0.01 Tw /Span<>> BDC
( )Tj
EMC
0.778 0 Td
[(Nunes V)129(, Neilson J, O\222Flynn N, Calvert N, Kuntze S, Smithson H, Benson J, Bl\
air J, Bowser A, Clyne W)73.9(, Cr)18(o)]TJ
0 Tw (-)Tj
0.048 Tw 0 -1.333 TD
[(me P)179(, Haddad P)179(, Hemingway S, Hor)-17.9(ne R, Johnson S, Kelly S, Packham B, Patel M, Steel J \(2009\). Clinical\
)]TJ
0.016 Tw 0 -1.333 TD
[(Guidelines and Evidence Review for Medicines Adher)18(ence: involving patients in decisions about pr)18(escribed )]TJ
0.11 Tw 0 -1.333 TD
[(medicines and supporting adher)18(ence. London: National Collaborating Centr)18(e for Primary Car)18(e and Royal )]TJ
0.021 Tw T*
[(College of General Practitioners. ROY)74(AL COLLEGE OF GENERAL PRACTITIONERS 14 Princes Gate, Hyde )]TJ
0 Tw 0 -1.333 TD
[(Park, London, SW7 1PU. www)55.1(.r)18(cgp.or)28.1(g.uk. Register)18(ed charity No 223106.)]TJ
/C0_1 1 Tf
-0.778 -2.667 Td
<00720001>Tj
/T1_1 1 Tf
-0.049 Tw /Span<>> BDC
( )Tj
EMC
0.778 0 Td
[(Medicines adher)18(ence: involving patients in decisions about pr)18(escribed medicines and supporting adher)18(ence. )]TJ
0 Tw T*
[(Disponible en: www)55.1(.nice.or)28.1(g.uk/CG76)]TJ
/C0_1 1 Tf
-0.01 Tc 0.01 Tw -0.778 -2.667 Td
<00720001>Tj
/T1_1 1 Tf
0.001 Tw /Span<>> BDC
( )Tj
EMC
0.758 0 Td
[(Documento de Buenas Pr\341cticas en Farmacia Comunitaria en Espa\361a. D\
isponible en: http://www)54.9(.portalfarma.)]TJ
0.01 Tw T*
[(com/Pr)18(ofesionales/Buenas-practicas-pr)18(ofesionales/Paginas/Buenas-practicas-Farmacia-Comunitaria.aspx)]TJ
/C0_1 1 Tf
0 Tc 0 Tw -0.758 -2.667 Td
<00720001>Tj
/T1_1 1 Tf
0.026 Tw /Span<>> BDC
( )Tj
EMC
0.778 0 Td
(Gu\355a Pr\341ctica para los Servicios de Atenci\363n Farmac\351utica en\
la Farmacia Comunitaria. FORO AF-FC. Dis)Tj
0 Tw (-)Tj
0.256 Tw T*
[(ponible en: http://www)55.1(.portalfarma.com/Inicio/atencionfarmaceutica/for)18(ofarmaciacomunitaria/Documents/)]TJ
0 Tw 0 -1.333 TD
[(A)92(TFC_Guia%20FORO.pdf)]TJ
/C0_1 1 Tf
-0.778 -2.667 Td
<00720001>Tj
/T1_1 1 Tf
0.066 Tw /Span<>> BDC
( )Tj
EMC
0.778 0 Td
[(Estrategia para el abor)18(daje de la cr)18(onicidad en el Sistema Nacional de Salud. 2012. Madrid: Ministerio de )]TJ
0.012 Tw T*
[(Sanidad, )0.5(Servicios )0.5(Sociales )0.5(e )0.5(Igualdad. )0.6(Disponible )0.5(en: )0.5(http://www)55(.msssi.gob.es/or)28(ganizacion/sns/planCali)]TJ
0 Tw (-)Tj
T*
[(dadSNS/pdf/ESTRA)92.1(TEGIA_ABORDAJE_CRONICIDAD.pdf [acceso, 25 de febr)18(er)18(o de 2014].)]TJ
/C0_1 1 Tf
-0.778 -2.667 Td
<00720001>Tj
/T1_1 1 Tf
0.061 Tw /Span<>> BDC
( )Tj
EMC
0.778 0 Td
[(Grupo de Expertos de For)18(o de Atenci\363n Farmac\351utica. Documento de Consenso, ener)18.1(o de 2008. Madrid: )]TJ
0.009 Tw T*
(Consejo General de Colegios O\037ciales de Farmac\351uticos. ISBN 978-84\
-691-1243-4, )Tj
/T1_2 1 Tf
(incluido como pie de )Tj
0 Tw 0 -1.333 TD
(p\341gina)Tj
/T1_1 1 Tf
(.)Tj
/C0_1 1 Tf
-0.778 -2.667 Td
<00720001>Tj
/T1_1 1 Tf
-0.038 Tw /Span<>> BDC
( )Tj
EMC
0.778 0 Td
[(Rodr\355guez-Chamorr)18.1(o MA, Gar)18.1(c\355a-Jim\351nez E, Rodr\355guez-Chamorr)18(o A, P\351r)18(ez Merino EM, Mart\355nez-Mart\355nez F)157(. )]TJ
-0.055 Tw T*
(Adaptaci\363n del estado de situaci\363n al documento de consenso en ate\
nci\363n farmac\351utica de\037nido por FORO. )Tj
0 Tw 0 -1.333 TD
(Ars Pharm. 2011; 52 \(suppl 1\): 35-9.)Tj
/C0_1 1 Tf
-0.778 -2.667 Td
<00720001>Tj
/T1_1 1 Tf
-0.003 Tw /Span<>> BDC
( )Tj
EMC
0.778 0 Td
[(Sabater )0.6(D, Silva )0.5(M, )0.5(Faus )0.5(MJ. )0.5(M. )0.5(M\351todo )0.5(D\341der)92.1(, )0.5(Gu\355a )0.5(de )0.5(Seguimiento )0.5(Farmacoterap\351utico. Grupo )0.5(de )0.5(Inves)]TJ
0 Tw (-)Tj
T*
[(tigaci\363n en Atenci\363n Farmac\351utica. Universidad de Granada. GI)0.5(AF-UGR. T)111(er)18(cera edici\363n, 2007.)]TJ
/C0_1 1 Tf
-0.778 -2.667 Td
<00720001>Tj
/T1_1 1 Tf
-0.005 Tw /Span<>> BDC
( )Tj
EMC
0.778 0 Td
[(Gastelurrutia )0.6(MA, )0.5(Faus )0.5(MJ )0.5([letter )0.6(to )0.5(the )0.5(editor]. )0.5(Dif)18(fer)18.1(ent )0.5(ways of practicing pharmaceutical )0.5(car)18.1(e. )0.5(Res )0.5(Social )]TJ
0 Tw T*
(Adm Pharm. 2009; 5 \(1\): 1-2.)Tj
/C0_1 1 Tf
-0.778 -2.667 Td
<00720001>Tj
/T1_1 1 Tf
0.028 Tw /Span<>> BDC
( )Tj
EMC
0.778 0 Td
[(Ley 41/2002, de 14 de noviembr)18.1(e, b\341sica r)18(eguladora de la autonom\355a del paciente y de der)18.1(echos y obliga)]TJ
0 Tw (-)Tj
-0.007 Tw T*
(ciones en materia de informaci\363n y documentaci\363n cl\355nica. BOE 2\
002; 274: 40126-32. Disponible en: http://)Tj
0 Tw T*
[(www)55(.boe.es/boe/dias/2002/11/15/pdfs/A40126-40132.pdf)]TJ
/C0_1 1 Tf
-0.778 -2.667 Td
<00720001>Tj
/T1_1 1 Tf
0.038 Tw /Span<>> BDC
( )Tj
EMC
0.778 0 Td
[(Ley 29/2006, de 26 de julio, de garant\355as y uso racional de los medic\
amentos y pr)18(oductos sanitarios. BOE )]TJ
0.283 Tw T*
[(2006; 178: 28122-65. Disponible en: http://www)55.1(.portalfarma.com/Pr)18.1(ofesionales/legislacion/r)18(ecopilacion/)]TJ
/Span<>> BDC
( )Tj
EMC
0 Tw 0 -1.333 TD
(Paginas/leygarantiasyusoraciona.aspx)Tj
/C0_1 1 Tf
-0.778 -2.667 Td
<00720001>Tj
/T1_1 1 Tf
0.033 Tw /Span<>> BDC
( )Tj
EMC
0.778 0 Td
[(Ley Or)28(g\341nica 15/1999, de 13 de diciembr)18.1(e, de Pr)18.1(otecci\363n de Datos de Car\341cter Personal. BOE 1999; 298: )]TJ
0 Tw T*
[(43088-99. Disponible en: http://www)55.2(.boe.es/boe/dias/1999/12/14/pdfs/A43088-43099.pdf)]TJ
/C0_1 1 Tf
-0.778 -2.667 Td
<00720001>Tj
/T1_1 1 Tf
0.029 Tw /Span<>> BDC
( )Tj
EMC
0.778 0 Td
[(Real Decr)18.1(eto 1720/2007, de 21 de diciembr)18(e, por el que se aprueba el Reglamento de desarr)18(ollo de la Ley )]TJ
0.033 Tw T*
[(Or)28(g\341nica 15/1999, de 13 de diciembr)18(e, de pr)18(otecci\363n de datos de car\341cter personal. Disponible en: http://)]TJ
0 Tw 0 -1.333 TD
[(www)55(.boe.es/boe/dias/2008/01/19/pdfs/A04103-04136.pdf)]TJ
/C0_1 1 Tf
-0.778 -2.667 Td
<00720001>Tj
/T1_1 1 Tf
-0.006 Tw /Span<>> BDC
( )Tj
EMC
0.778 0 Td
[(Rodr\355guez Chamorr)18(o M\301, Gar)18(c\355a-Jim\351nez E, Amariles P)179(, Rodr\355guez Chamorr)18(o A, Faus MJ. Revisi\363n de tests )]TJ
-0.036 Tw T*
(de medici\363n del cumplimiento terap\351utico utilizados en la pr\341ct\
ica cl\355nica. Aten Primaria. 2008; 40 \(8\): 413-7.)Tj
ET
q
0 0 643.417 890.031 re
W n
/CS1 CS 0 SCN
1.25 w
q 1 0 0 1 15 865.9606 cm
0 0 m
-15 0 l
613.417 0 m
628.417 0 l
0 -841.89 m
-15 -841.89 l
613.417 -841.89 m
628.417 -841.89 l
9.071 9.071 m
9.071 24.071 l
9.071 -850.961 m
9.071 -865.961 l
604.346 9.071 m
604.346 24.071 l
604.346 -850.961 m
604.346 -865.961 l
S
Q
1 SCN
0.25 w
q 1 0 0 1 15 865.9606 cm
0 0 m
-15 0 l
613.417 0 m
628.417 0 l
0 -841.89 m
-15 -841.89 l
613.417 -841.89 m
628.417 -841.89 l
9.071 9.071 m
9.071 24.071 l
9.071 -850.961 m
9.071 -865.961 l
604.346 9.071 m
604.346 24.071 l
604.346 -850.961 m
604.346 -865.961 l
S
Q
Q
endstream
endobj
35 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Subtype/Form>>stream
0.69 0.53 0 0 K
1.5 w 1 j 1 J [0 4.52]0 d
/GS0 gs
q 1 0 0 1 141.6315 819.4915 cm
0 0 m
404.547 0 l
S
Q
[]0 d
q 1 0 0 1 137.1115 819.4915 cm
0 0 m
0 0 l
411.328 0 m
411.328 0 l
S
Q
BT
0.552 0.424 0 0 k
/TT0 1 Tf
0.03 Tc 0 Tw 0 Ts 100 Tz 0 Tr 8 0 0 8 136.3615 824.4934 Tm
[(Buenas Pr)21.5(\341ctic)5.4(as en F)27.4(armacia Co)0.5(munit)10.1(aria en Espa\361a)]TJ
/CS0 cs 1 scn
/TT1 1 Tf
0 -1.959 TD
[(Se)0.5(r)-8.9(vicio de)0.5( Adher)13.6(encia T)88.6(er)20.9(ap\351utic)8.4(a en F)26.4(armacia Comunit)12.2(aria)]TJ
ET
/CS0 cs 1 scn
94.937 806.654 36.768 25.29 re
f
BT
0 0 0 0 k
/TT0 1 Tf
0 Tc 27.0994 0 0 27.0994 99.5858 810.7062 Tm
(10)Tj
ET
q
15.567 15.567 42.52 858.897 re
W n
q
0 861.0884628 44.7288893 0 14.4978139 14.3826193 cm
/Im0 Do
Q
Q
endstream
endobj
45 0 obj
<>stream
Adobe d C
m !1QAaq"2BRbr3CS#$
%&'()*456789:DEFGHIJTUVWXYZcdefghijstuvwxyz ? rm 'VhEmF)]\m?ңRZj1~ku?6c,ό{.:[Gj\_dL |-%
ƩR=InO#[ʶuaO
Iߑظ2'8;鶹Yod^>oR[%5%Υ=&,Nt->*|GqTu!~SWgH\Q_4ī}sB $ٳ5kR{-2IR.7'}.! <,'+Zߢ<[POPQ/J6BBG ;0FU'C&BGϬ~ښktoxPvZ1,[ X:jA&Gά/ůrڜn>QBY#-ډIq[\G?A5.SrSߡ)LJ^jObD̟K9Tۓ" }A٢ЁX'_.iZqP gL=*|͢a1T11וIm|{dʼ`t\˓S+\;']*wov}W 'Kjjt1 -G Y |jʼ)6|m\ç9{R]:kPz0A(T,ڎ@Z'Rtkҧآ]B e\-N8x]PiOQ\kV?qʙJ2l+iy-Ӟ.U/̔ ȸSޢװ80}Ir'ԵxI.δQWRnarwF-q; u!ODN4+hqVP*>aXb*zSKrr}.}e{E(P> hU\喜
\:J4bK{) pWɔq^[6a.Mr=~͈^Ir?gFT]|v,̥#)gv>>\;a'ɹ[iT.<'xK'+S6.mXj=eN>Yk?+Oj>eaP?,;(%KV:RƯ#ΐ?T[>|J6g